Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 6/20 | 0.38 |
| ▸ | ADH1C | P00326 | 4/20 | 0.38 |
| ▸ | ADH1B | P00325 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL810839 | 0.78 | ADH1C (0.38) | ADH1AADH1CADH1BCYP1A2CYP2D6 | |
| SCHEMBL11622032 | 0.78 | ADH1C (0.38) | ADH1AADH1CADH1BCYP1A2CYP2D6 | |
| SCHEMBL11626207 | 0.78 | ADH1C (0.38) | ADH1AADH1CADH1BCYP1A2CYP2D6 | |
| SCHEMBL12810164 | 0.73 | ADH1A (0.38) | ADH1AADH1CADH1BCYP1A2CYP2D6 | |
| SCHEMBL16822345 | 0.73 | ADH1A (0.38) | ADH1AADH1CADH1BCYP1A2CYP2D6 | |
| SCHEMBL16822357 | 0.73 | ADH1A (0.38) | ADH1AADH1CADH1BCYP1A2CYP2D6 | |
| SCHEMBL543417 | 0.72 | ADH1A (0.45) | ADH1AADH1CADH1B | |
| SCHEMBL2231395 | 0.71 | KDM4E (0.33) | — | |
| SCHEMBL16822339 | 0.71 | ADH1C (0.35) | ADH1AADH1CADH1BCYP1A2CYP2D6 | |
| SCHEMBL4343391 | 0.71 | EPHX1 (0.33) | CYP1A2CYP2D6CYP2C19TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101778814-B | There is the aldehyde of hydroxyl | SIKA技术股份公司 | 2016-08-03 | — | — | CN | disclosed |
| US-8389772-B2 | Aldehydes containing hydroxl groups | SIKA TECHNOLOGY AG (CH) | 2013-03-05 | — | — | US | disclosed |
| US-20110195242-A1 | ALDEHYDES CONTAINING HYDROXL GROUPS | SIKA TECHNOLOGY AG (CH) | 2011-08-11 | — | — | US | disclosed |
| CN-101778814-A | aldehydes containing hydroxyl groups | SIKA TECHNOLOGY AG | 2010-07-14 | — | — | CN | disclosed |
| EP-2200970-A1 | ALDEHYDES CONTAINING HYDROXYL GROUPS | Sika Technology AG (CH) | 2010-06-30 | — | — | EP | disclosed |
| WO-2009027510-A1 | ALDEHYDES CONTAINING HYDROXYL GROUPS | SIKA TECHNOLOGY AG (CH) | 2009-03-05 | — | — | WO | disclosed |
| EP-2030965-A1 | Aldehydes containing hydroxyl groups | Sika Technology AG (CH) | 2009-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195242-A1 | ALDEHYDES CONTAINING HYDROXL GROUPS | ALDH7A1, ALDH1A1, AOX1 | ADH1A 128/4885ADH1C 236/4885ADH1B 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.